This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Max-Delbruck-Centrum Fur Molekulare Medizin (Mdc) Berlin-Buch, Max-Delbrueck-Centrum Fuer Molekulare Medizin. Active years: 2015.
Company Filing History:
1 out of 6 
1 out of 18 Years Active: 2015
Title: Jehad Charo: Innovator in Molecular Biology
Introduction
Jehad Charo is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of molecular biology, particularly in the development of innovative methods for protein expression and therapeutic applications. With a total of 2 patents, his work has the potential to impact medical science and treatment methodologies.
Latest Patents
Charo's latest patents include groundbreaking inventions. The first patent, titled "Epitope-tag surface expressed proteins and nucleic acids thereof," relates to a method for selecting a host cell population that expresses a functional fusion protein. This fusion protein comprises at least one epitope-providing amino acid sequence and the amino acid sequence of a protein expressed on the surface of the host cell. This invention is particularly relevant for applications in medicine, especially in the context of adoptive transfer therapies.
The second patent, "Use of Pol III promoters for controlled expression of therapeutic proteins," focuses on expression systems that modulate the expression of protein-coding target genes. This invention utilizes RNA polymerase III-based methods and systems for the expression of therapeutic proteins in cells, both in vivo and in vitro.
Career Highlights
Throughout his career, Jehad Charo has worked with esteemed institutions, including the Max Delbrück Center for Molecular Medicine. His research has contributed to advancements in molecular biology and therapeutic protein expression, showcasing his commitment to innovation in the field.
Collaborations
Charo has collaborated with notable colleagues such as Thomas Blankenstein and Elisa Kieback. These partnerships have further enriched his research and development efforts, leading to impactful scientific advancements.
Conclusion
Jehad Charo's contributions to molecular biology through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in therapeutic applications and protein expression methodologies.